Evaluating the bioequivalence of levetiracetam brand and generic oral tablets available in the Saudi market in vivo

BACKGROUND: Epilepsy is a common global neurological disorder. About 30% of epileptic patients are managed with anti-epileptic Drugs (AEDs). Since 2000, Levetiracetam (LEV) has been marketed around the world as an AED under the brand name Keppra, and recently more generics are found in the Saudi mar...

Descripción completa

Detalles Bibliográficos
Autores principales: ALRabeeah, Danah, Almomen, Aliyah, Alzoman, Nourah, Arafah, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518482/
https://www.ncbi.nlm.nih.gov/pubmed/37753207
http://dx.doi.org/10.1016/j.jsps.2023.101758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518482/
https://www.ncbi.nlm.nih.gov/pubmed/37753207
http://dx.doi.org/10.1016/j.jsps.2023.101758

Ejemplares similares